Company
Annovis Bio Inc.
Annovis Bio Inc. has 1 drug tracked on RxWires: 1 in Phase 2/3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| buntanetap/posiphen | Phase 2/3 | Alzheimer's Dementia (AD) |
Latest
No recent events.
Follow Annovis Bio Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.